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Thymomas represent the most common mediastinal neoplasm constituting about 20% of all mediastinal tumors in adult population. The overall incidence is rare however; with 0.15 cases per 100.000 (1) . Thymoma is an epithelial tumor, mostly solid in nature and completely surrounded by a fibrous capsule. Thymomas are generally considered to have an indolent growth pattern, however 34% may invade through the capsule into the pleura, pericardium, great vessels, right atrium, lung, or even cause systemic metastases (2, 3) . The term invasive thymoma is preferred to malignant thymoma because invasive thymomas lack the histologic features of malignancy and are microscopically identical to encapsulated thymomas.
Invasive thymoma can sometimes mimic malignant pleural mesothelioma by diffusely involving the pleura and encasing entire lung (4) (5) (6) . In this manuscript we represent a case of invasive thymoma presenting with diffuse pleural thickening recurred 11 years later. Environmental asbest exposure was a challenge for preliminary diagnosis before VATS-pleural biopsy.
CASE REPORT
A 50-year-old man admitted with one month history of exertional dyspnea, weight loss, and mild pleuritic chest pain. He lost ten kilograms of body weight. He denied cough, hemoptysis, wheeze, fever, or night sweats. He was a building constractor. He had a smoking history of 50 pack-years and environmental asbestos exposure from birth to 12-years-old. In his past medical history, he had had a maximal thymectomy operation and adjuvant radiotherapy with the diagnosis of minimally invasive lymphocytic thymoma 11 years ago.
On physical examination, vital signs were within normal ranges. There was a median sternotomy scar. There was dullness and decreased breath sounds on the left hemithorax. Other systems were normal. Rutine laboratory examinations including complete blood count, biochemical analysis, urine analysis, erythrocyte sedimentation rate (ESR) were within normal limits apart from a high level of lactate dehydrogenase (LDH: 552 U/L) and ESR: 33 mm/hour. A diagnostic thoracentesis from the left hemithorax revealed hemorrhagic pleural effusion. Effusion was a lymphocytic (95% lymphocytes) exudate (pleural LDH: 1571 U/L).
A chest radiograph (Figure 1 ) demonstrated pleural thickening, nodularity, and effusion on the left hemithorax. Also there was pleural irregularity on the right costal pleura. A computed tomography of thorax ( Figure 2 ) demonstrated circumferential pleural thickening which encases the entire lung and pleural effusion. There were pleural nodularity and masses predominantly on the left hemithorax. A few borderline-sized aortopulmonary and subcarinal lymph nodes were present.
Since a closed pleural biopsy was undiagnostic, the patient was referred to chest surgery clinic for VATS-pleural biopsy. Histologic examination of the pleura showed a tumor characterized by well developed lobules which were seperated by fibrous septas of variable thickness ( Figure 3 ). The lobules were composed of a prominent population of lymphocytes and scattered epithelial cells. Köksal 
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Tuberk Toraks 2012; 60(1): 62-65 The lymphoid component is a densely packed population of small lymphocytes which have clumped chromatine. The neoplastic epithelial component was relatively inconspicuous and appeared as interspersed oval cells with pale round nuclei and small nucleoli. Mitoses were rare. At sides of adhesion the lung parenchyma were invaded by tumor cells. Immunohistochemical stains were performed on paraffin-embedded sections by the avidinbiotin-peroxidase complex method. Pancytokeratin and CK5/6 immunostains showed an arborizing network of reactivity, but they were negative for calretinin ( Figure  4 ). The lymphocytes stained strongly positive for CD3 and focally positive for CD5, CD1a and TdT. The patient was diagnosed as invasive tymoma, Type B1 (lymphocytic predominantly cortical). The disease stage was IVA based on pleural and pericardial dissemination by Masaoka Staging System (7). The patient was referred to medical oncology clinic for chemotherapy.
DISCUSSION
In this patient presenting with pleuretic chest pain and circumferential pleural thickening, the differential diagnosis comprises the infectious etiology, empyema, fibrothorax, lymphoma, metastasis, and mesothelioma (8) . The absence of fever and leucocytosis exclude the infectious etiology. Hemorrhagic pleural effusion, which was an exudate rich in lymphocytes suggested a chronic and probably malignant process. Turkey is an endemic region for mesothelioma and environmental asbest exposure is the etiologic factor (9,10). The history of environmental asbest exposure for 12 years and the typical radiology highly suggested the diagnosis of mesothelioma. Weight loss more than 10% of the body weight in a one month period supported this diagnosis but the absence of chest pain was challenging. Recurrence of thymoma was not the most likely diagnosis as malignant pleural mesothelioma, since there was a long period of time (11 years) from the initial diagnosis. Evaluating the literature, the recurrence of thymomas is reported up to 10-30% of the patients. And there are cases reported recurred more than 10 years after complete surgical resection (11, 12) . Thymoma can mimic malignant pleural mesothelioma by diffusely involving the pleura and encasing the entire lung (4-6). For a definite diagnosis VATS pleural biopsy was performed.
The differential diagnosis of diffuse pleural abnormalities includes malignant diseases such as pleural metastases of adenocarcinomas (mainly lung, breast, ovary, gastrointestinal tract), mesothelioma, and lymphoma, as well as benign conditions such as fibrothorax, tuberculous pleural thickening, post or present empyema, asbestos related pleural effusions and plaques (13) . The typical appearance of thymomas is a subtle contour abnormality in the anterior mediastinum which can be indistinguishable from cardiac contour and simulate cardiac enlargement. With pleural dissemination, an irregular interface between the mass and the adjacent lung is characteristic (14) . Pleural spread manifests either as isolated pleural nodules (droplet metastasis) or as a contiguous pleural mass often mimicking mesothelioma (5). Pleural effusions are uncommon (15) . Predominantly pleural thickening that encasing the entire lung is a very rare presentation. In this type of presentation it is hard to make an accurate radiological differentiation of thymoma from diffuse malignant mesothelioma (12) .
Histologically thymomas can be classified according to the predominant cell type. This tumor was classified as "Type B1 lymphocytic predominantly cortical" according to the World Health Organization Classification System (16) . Pleural thymomas rarely diffusely efface the pleural space in one or both hemithoraces, reproRecurrence of thymoma after 11 years presenting as diffuse pleural thickening
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Tuberk Toraks 2012; 60(1): 62-65 Masaoka staging system is the most widely used staging system, which incorporates the presence of invasion and the anatomic extent of involvement as defined both clinically and histopathologically (7). The patient was stage IVA due to pleural and pericardial dissemination. At this stage chemotherapy was the treatment of choice. For this reason he was referred to medical oncology clinic.
In conclusion, in a patient with diffuse pleural abnormalities, apart from the most common etiologies such as mesothelioma, metastatic carcinoma or lymphoma, other exceptional etiologies as in this patient with invasive thymoma must be taken into account. The recurrence of thymomas may be as long as 10 years after complete resection.
